IRIS
TONTINI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.689
EU - Europa 6.887
AS - Asia 3.813
SA - Sud America 248
AF - Africa 32
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 13
Totale 21.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.585
GB - Regno Unito 2.422
CN - Cina 2.142
IT - Italia 1.056
UA - Ucraina 1.038
SG - Singapore 875
SE - Svezia 606
FI - Finlandia 394
TR - Turchia 392
DE - Germania 385
RU - Federazione Russa 334
IE - Irlanda 254
BR - Brasile 190
VN - Vietnam 133
FR - Francia 128
CA - Canada 81
NL - Olanda 77
IN - India 75
BE - Belgio 51
JP - Giappone 42
KR - Corea 32
PL - Polonia 29
ES - Italia 26
AR - Argentina 24
AT - Austria 18
HK - Hong Kong 18
AU - Australia 16
RO - Romania 16
BD - Bangladesh 15
ID - Indonesia 14
EU - Europa 12
MX - Messico 12
SA - Arabia Saudita 11
KE - Kenya 10
ZA - Sudafrica 10
CL - Cile 9
IR - Iran 9
LT - Lituania 9
IQ - Iraq 8
CH - Svizzera 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
PK - Pakistan 6
AL - Albania 5
NZ - Nuova Zelanda 5
PE - Perù 5
IL - Israele 4
PH - Filippine 4
PY - Paraguay 4
SM - San Marino 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
GR - Grecia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
LV - Lettonia 3
MA - Marocco 3
PT - Portogallo 3
SI - Slovenia 3
TW - Taiwan 3
VE - Venezuela 3
AM - Armenia 2
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
FK - Isole Falkland (Malvinas) 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
TG - Togo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
UG - Uganda 1
ZW - Zimbabwe 1
Totale 21.703
Salva come PNG Salva come JPEG
Città #
Southend 2.214
Dallas 1.261
Woodbridge 1.188
Ann Arbor 884
Houston 838
Jacksonville 829
Fairfield 775
Chandler 766
Ashburn 698
Nanjing 442
Singapore 379
Cambridge 367
Wilmington 318
Beijing 315
Seattle 295
Izmir 287
Dublin 199
Boardman 188
Nanchang 178
San Mateo 146
Helsinki 145
Princeton 119
New York 114
Hebei 92
Shenyang 91
Los Angeles 84
Changsha 83
Tianjin 76
Munich 69
Düsseldorf 68
Jiaxing 67
Istanbul 59
Velikiy Novgorod 56
Amsterdam 53
Brussels 50
Des Moines 50
Ho Chi Minh City 48
Menlo Park 48
Shanghai 47
Santa Clara 46
Kunming 43
Moscow 43
Council Bluffs 41
Milan 40
Bremen 36
Guangzhou 36
San Francisco 35
Toronto 35
Buffalo 32
San Diego 31
London 30
Jinan 29
Seongnam 28
Urbino 28
Nuremberg 27
Rome 27
Hanoi 24
Warsaw 24
Mülheim 23
Venice 23
Lanzhou 22
Ningbo 21
Stockholm 21
Zhengzhou 21
Changchun 20
Dearborn 20
São Paulo 20
Hangzhou 19
Montreal 18
Frankfurt am Main 17
Haikou 17
Ancona 16
Denver 16
Chicago 15
Parma 15
Taizhou 15
Tokyo 15
Dong Ket 14
Norwalk 14
Redwood City 14
Shenzhen 14
Vienna 14
Brooklyn 13
Cava De' Tirreni 13
Chennai 13
Hong Kong 13
Palermo 13
Turku 13
Ankara 12
Auburn Hills 12
Florence 12
Orem 12
Phoenix 11
Augusta 10
Hefei 10
Manchester 10
Napoli 10
Padova 10
Wuxi 10
Leawood 9
Totale 15.251
Salva come PNG Salva come JPEG
Nome #
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 1.278
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 836
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 413
Pharmacokinetics, pharmacodynamics and safety studies on URB 937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats 359
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 328
A New Synthesis of 2-Substituted DL-Tryptophan Derivatives 270
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 266
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 265
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 257
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 257
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 255
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 252
An improved route to cycloalka[b]pyrrole 2-carboxylates 240
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 240
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 235
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 228
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 228
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 222
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 221
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 221
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 216
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 216
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 216
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 214
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 208
An endocannabinoid mechanism for stress-induced analgesia 206
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 205
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 204
Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a "needle" according to the recent homonymous concept 202
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 201
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 198
Peripherally Restricted FAAH Inhibitors 197
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 194
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 194
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 193
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 192
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 191
2-N-Acylaminoalkylindoles: Design and Quantitative Structure-Activity Relationship Studies Leading to MT2-Selective Antagonists. 190
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 189
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 186
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 185
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 184
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 183
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 182
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 181
Modulation of anxiety through blockade of anandamide hydrolysis 181
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 180
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 178
Electron Impact Ionization and Fast Atom Bombardment Mass Spectrometry of Some 3,3-Dimethyl-1-(Isoxazol-3-yl)-triazenes. A New Class of Potential Anticancer Agents. 176
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 175
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice 174
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 174
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 174
Synthesis and Structure–Activity Relationship Studies of O-Biphenyl-3-yl Carbamates as Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitors 173
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 172
Nitroisoxazoles by manganese(IV) oxide oxidation of nitro-4,5-dihydroisoxazoles. 171
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues 170
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597) 169
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships 168
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 168
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 166
Synthesis and Structure-Activity/Stability Relationships of Carbamate Inhibitors of the FAAH Enzyme 165
Selective inhibition of 2 - AG hydrolysis enhances endocannabinoid signaling in the hippocampus 164
Mimosine induces apoptosis in the HL60 human tumor cell line. 164
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 163
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 159
Identification of a Bioactive Impurity Present in a Sample of URB754 158
A linear relationship between MS/MS data and FAAH inhibitory activity of some carbamates 158
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 154
Sintesi e studi di relazione struttura–attività/selettività su O-bifenil-3-ilcarbammati disostituiti quali inibitori periferici dell’enzima FAAH 154
3D-QSAR study of carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 148
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation 147
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 147
Rotation about the N2-N3 bond in 3,3-dimethyl-1-(isoxazol-3-yl)triazene 145
Synthesis and pharmacological characterization of URB447, a new cannabinoid receptor neutral antagonist 145
Antinociceptive effects of the brain-impermeant fatty-acid amide hydrolase inhibitor URB937 143
Tandem mass spectrometric data–FAAH inhibitors activity relationships of some carbamic acid O-aryl esters 140
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 135
Inhibitors of lysosomal lipid amidase NAAA 135
Synthesis of 1-(isoxazol-3-yl)triazene derivatives. Antimetastatic activity of 3,3-dimethyl-1-(5-methylisoxazol-3-yl)triazene. European Journal of Medicinal Chemistry (1996), 31(9), 735-740. 134
QSAR and molecular modelling investigations of a new series of alkyl carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 134
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 133
FAAH and MGL Inhibitors. Design and Therapeutic Implications 133
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 132
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 130
Seamus Heaney: una poesia del movimento 130
Cannabinoids Modify Hippocampal Serotonergic Transmission 129
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 129
Synthesis and Pharmacological Characterization of Potent and Selective Inhibitors of Fatty Acid Amidohydrolase (FAAH) 128
Methods, Compositions, and Other Compounds for Modulation of Monoacylglycerol Lipase Pain, and Stress-related Disorders 127
Correlation between energetics of collisionally activated decompositions, interaction energy and biological potency of carbamates FAAH inhibitors 124
Design, Synthesis and SAR of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acids Amide Hydrolase Inhibitors 123
Synthesis and Biological Activity of Monoacylglycerol Lipase (MGL) Inhibitor URB602 and its Analogs 122
Insight into the mechanism of carbamate inactivation of FAAH by QM/MM modelling study 120
Correlation of the mutagenic properties of aryl- and heteroaryl-triazenes with their electron ionization induced fragmentation 117
Mass Spectrometry and Pharmacology Activity: The Case of Carbamic Analogs 117
Synthesis, QSAR and Pharmacological Evaluation of Alkylcarbamic Acid Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: A Novel Approach to Antianxiety and Analgesic Agents 117
Differences between direct cannabinoid agonists and FAAH inhibitors on antidepressant-like behavioural and serotonin-modulatory activity 116
Structure–Activity and Structure–Property Relationships of N-(2-Oxo-3-Oxetanyl)carbamic Acid Esters as N-Acylethanolamine-hydrolyzing Acid Amidase (NAAA) Inhibitors 115
Esteri bifenil-3-ilici dell'acido cicloesilcarbammico quali inibitori dell'enzima FAAH: sintesi, QSAR e modellistica molecolare 114
Totale 19.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.347
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.245 0 0 0 0 0 156 93 143 273 178 290 112
2021/20221.321 89 171 142 183 40 36 62 66 87 67 18 360
2022/20232.159 254 135 68 288 186 451 16 174 335 65 113 74
2023/2024569 70 44 51 74 36 120 22 36 10 46 14 46
2024/20251.891 109 104 474 128 59 146 216 94 156 131 137 137
2025/20263.446 381 698 1.214 773 357 23 0 0 0 0 0 0
Totale 21.845